Latest news
RiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 07:28:07 GMTFDA Clears IND for RiboX’s RXIM002, Circular RNA CAR-T for ITP - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 06:34:09 GMTThe Brain Is the Frontier: Inside the Trial That’s Rewriting the CAR-T Playbook for Glioblastoma - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 07:31:37 GMTCAMP4 advances rare disease treatment for SYNGAP1 into human trials - CNBCCNBC · Thu, 06 Aug 2026 18:52:12 GMTThe PTSD Nightmare Drug No One Expected: What Dronabinol’s RCT Tells Us About CNS Trial Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 07:34:28 GMTTenaya’s TN-201 Gene Therapy Shows Hypertrophy Reduction in HCM Patients - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMTThe Future of Immuno-Oncology Clinical Trial Design – SITC - OncodailyOncodaily · Mon, 03 Aug 2026 18:20:56 GMTThe Clinical Trial That Asks Whether Your Current Treatment Should Exist - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 02 Aug 2026 07:28:08 GMT